XML 42 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Goodwill
12 Months Ended
Dec. 31, 2018
Text block [abstract]  
Goodwill
18. GOODWILL

 

    Cost   Accumulated impairment   Carrying amount
    NT$   NT$   NT$
             
Balance at January 1, 2016   $ 12,495,515     $ 1,988,996     $ 10,506,519  
Acquisitions through business combinations (Note 30)     15,323       -         15,323  
Effect of foreign currency exchange differences     (31,533 )     -         (31,533 )
Balance at December 31, 2016     12,479,305       1,988,996       10,490,309  
Impairment losses recognized     -         425,117       (425,117 )
Effect of foreign currency exchange differences     (130,698 )     -         (130,698 )
Balance at December 31, 2017     12,348,607       2,414,113       9,934,494  

 

    Cost   Accumulated impairment   Carrying amount
    NT$   NT$   NT$
             
Acquisition through business combinations  (Note 30)   $ 39,990,231     $ -       $ 39,990,231  
Effect of foreign currency exchange differences     49,721       -         49,721  
                         
Balance at December 31, 2018   $ 52,388,559     $ 2,414,113     $ 49,974,446  

 

    Cost   Accumulated impairment   Carrying amount
    US$ (Note 4)   US$ (Note 4)   US$ (Note 4)
             
Balance at January 1, 2018   $ 403,418     $ 78,867     $ 324,551  
Acquisition through business combinations (Note 30)     1,306,443       -         1,306,443  
Effect of foreign currency exchange differences     1,624       -         1,624  
                         
Balance at December 31, 2018   $ 1,711,485     $ 78,867     $ 1,632,618  

 

a. Allocating goodwill to cash-generating units

 

Goodwill had been allocated to the following cash-generating units for impairment testing purposes: packaging segment, testing segment, EMS segment and other segment. The carrying amounts of goodwill allocated to cash-generating units were as follows:

 

    December 31
    2017   2018
Cash-generating units   NT$   NT$   US$ (Note 4)
             
Packaging segment   $ 1,362,724     $ 35,729,371     $ 1,167,245  
Testing segment     7,775,581       13,448,886       439,362  
Others     796,189       796,189       26,011  
                         
    $ 9,934,494     $ 49,974,446     $ 1, 632,618  

 

b. Impairment assessment

 

At the end of each year, the Group performs impairment assessment by reviewing the recoverable amounts based on value in use which incorporates cash flow projections estimated by management covering a five-year period. The cash flows beyond that five-year period have been extrapolated using a steady per annum growth rate. In assessing value in use, the estimated future cash flows are discounted to their present value using annual discount rates which were 9.09%-10.49%, 8.97%-11.29% and 8.01%- 8.57% as of December 31, 2016, 2017 and 2018, respectively. The key assumption used in value in use calculations was the growth rates for operating revenue, which were based on the revenue forecast for the Group and the industry as well as the Group’s historical experience.

 

As of December 31, 2017, the recoverable amount of other segment was lower than its carrying amount since its actual growth in revenue did not meet its forecast previously made by management. The review led to the recognition of an impairment loss of NT$425,117 thousand under the line item of other operating income and expenses, net (Note 26) in the consolidated statements of comprehensive income for the year ended December 31, 2017.

 

Management believed that any reasonably possible change in the key assumptions on which recoverable amount would not cause the aggregate carrying amount of the cash-generating unit to exceed its aggregate recoverable amount significantly.